Tomohiro Kinoshita

Feasibility and pharmacokinetic study of a chimeric anti-CD20 monoclonal antibody (IDEC-C2B8, rituximab) in relapsed B-cell lymphoma. The IDEC-C2B8 Study Group.

M. Narabayashi, Y. Kagami, M. Ogura, 1998, Annals of oncology : official journal of the European Society for Medical Oncology.

Erythroid potentiating activity of tissue inhibitor of metalloproteinases on the differentiation of erythropoietin-responsive mouse erythroleukemia cell line, ELM-I-1-3, is closely related to its cell growth potentiating activity.

Y. Kagami, T. Kinoshita, S. Yoshida, 1993, Experimental hematology.

Phase I study of cladribine (2-chlorodeoxyadenosine) in lymphoid malignancies. Cladribine Study Group.

Y. Ohashi, M. Narabayashi, R. Suzuki, 1997, Japanese journal of clinical oncology.

Epstein-Barr virus (EBV) genome carrying monoclonal B-cell lymphoma in a patient with adult T-cell leukemia-lymphoma.

Y. Matsuno, K. Tobinai, T. Kinoshita, 1991, Leukemia research.

The MDM2 oncogene overexpression in chronic lymphocytic leukemia and low-grade lymphoma of B-cell origin.

T. Kinoshita, T. Uchida, T. Murate, 1994, Blood.

Mutations of p53 gene and their relation to disease progression in B-cell lymphoma.

K. Hayashi, T. Kinoshita, Y. Murakami, 1992, Blood.

High-risk myelodysplastic syndromes and hypermethylation of the p15Ink4B gene.

T. Kinoshita, T. Uchida, T. Murate, 1998, Leukemia & lymphoma.